772 related articles for article (PubMed ID: 32506598)
1. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M
Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598
[TBL] [Abstract][Full Text] [Related]
2. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
[TBL] [Abstract][Full Text] [Related]
3. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma.
Gao S; Xu X; Wang Y; Zhang W; Wang X
Mol Med Rep; 2018 Sep; 18(3):3305-3313. PubMed ID: 30066898
[TBL] [Abstract][Full Text] [Related]
5. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
6. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
7. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
[TBL] [Abstract][Full Text] [Related]
8. Exosome-transmitted long non-coding RNA
Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
[TBL] [Abstract][Full Text] [Related]
9. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
10. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes.
Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y
Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970
[TBL] [Abstract][Full Text] [Related]
11. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q
Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells.
Li B; Mao R; Liu C; Zhang W; Tang Y; Guo Z
Life Sci; 2018 Mar; 197():122-129. PubMed ID: 29421439
[TBL] [Abstract][Full Text] [Related]
14. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
Sasaki R; Kanda T; Yokosuka O; Kato N; Matsuoka S; Moriyama M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897788
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C
Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068
[TBL] [Abstract][Full Text] [Related]
16. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.
Wang T; Zhu H; Xiao M; Zhou S
J Clin Lab Anal; 2021 Nov; 35(11):e23959. PubMed ID: 34612554
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
18. Role of exosomal competing endogenous RNA in patients with hepatocellular carcinoma.
Abd El Gwad A; Matboli M; El-Tawdi A; Habib EK; Shehata H; Ibrahim D; Tash F
J Cell Biochem; 2018 Nov; 119(10):8600-8610. PubMed ID: 30015383
[TBL] [Abstract][Full Text] [Related]
19. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
[TBL] [Abstract][Full Text] [Related]
20. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
